Preimplantation genetic diagnosis may pose neurological risks

Jul 21, 2009

Preimplantation genetic diagnosis (PGD) has helped many couples conceive healthy children and is generally considered a safe practice. However, a new long-term analysis of PGD in mice suggests that this procedure may increase risks of weight gain and memory decline in adulthood.

PGD is used alongside assisted technologies to ensure couples that may be carriers of genetic disease (e.g. Ashkenazi Jews who have a high incidence of Tay-Sachs among their population) don't pass on defective genes to their children. While PGD is not believed to pose any serious health risks, the procedure does involve manipulating the developing embryo and no rigorous long-term studies have been carried out.

Ran Huo, Qi Zhou and colleagues used a mouse model to examine how a blastomere biopsy, as the key manipulation during the PGD procedure, could affect fetal, neonatal and adult development.

They found that there were no differences in prior to uterine implantation in the biopsied and control groups, which is consistent with results found in humans. However, following implantation, successful births from biopsied embryos were significantly lower than in controls.

Following birth, the authors tracked many physical and behavioral properties; the two groups of mice were similar in many respects, though mice in the biopsied group on average had higher body weight and poorer memory in maze tests. To get a more detailed picture of these memory defects, the authors performed a proteomic analysis of adult mouse brains; 36 proteins displayed significant differences between biopsied and control groups, 17 of which are closely associated with neurodegenerative disorders like Alzheimers and Down Syndrome.

The authors suggest that the developing nervous system may be sensitive to blastomere biopsy, and that more studies should be performed to address any possible long-term adverse effects of PGD to ensure its safety.

More information: "Evaluation of Blastomere Biopsy Using a Indicates the Potential High Risk of Neurodegenerative Disorders in the Offspring" by Yang Yu, Jindao Wu, Yong Fan, Zhuo Lv, Xuejiang Guo, Chun Zhao, Rong Zhou, Zhuo Zhang, Fuqiang Wang, Min Xiao, Ling Chen, Hui Zhu, Wen Chen, Min Lin, Jiayin Liu, Zuomin Zhou, Liu Wang, Ran Huo, Qi Zhou and Jiahao Sha, http://www.mcponline.org/cgi/content/full/8/7/1490

Source: American Society for Biochemistry and Molecular Biology

Explore further: New study finds blind people have the potential to use their 'inner bat' to locate objects

add to favorites email to friend print save as pdf

Related Stories

Britain expands embryo screening

May 11, 2006

Britain's fertility watchdog agency has approved expanded screening of embryos to include genetic links to ovarian, breast and colon cancers.

11-gauge needle better than 14-gauge in breast biopsy

Feb 02, 2009

Stereotactic vacuum-assisted breast needle biopsy, a common minimally invasive biopsy method used in the US, is more effective with an 11-gauge needle than the 14-gauge needle decreasing a physician's chances of false-negative ...

Recommended for you

Germ-fighting vaccine system makes great strides in delivery

2 hours ago

A novel vaccine study from South Dakota State University (SDSU) will headline the groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference ...

Discovery of novel medicine for treatment of chronic wounds

7 hours ago

Every 20 seconds, a limb is lost as a consequence of diabetic foot ulcer that does not heal. To date, medical solutions that can change this situation are very limited. In his doctoral thesis Yue Shen from the Industrial ...

Lymphatic fluid takes detour

7 hours ago

When tumours metastasise, they can block lymphatic vessels, as researchers from ETH Zurich have discovered using a new method. The lymphatic fluid subsequently has to find a new path through the tissue. Such ...

User comments : 0

More news stories

Tiny, implantable coil promises hope for emphysema patients

A small, easily implantable device called the Lung Volume Reduction Coil (LVRC) may play a key role in the treatment of two types of emphysema, according to a study conducted in Europe. Results of the study indicate the beneficial ...